Page 8 - PHPCN 2019 Annual Conference

Educational Workshop Schedule

THURSDAY, MAY 2, 2019

SESSION 2 − 11:30 AM–1:00 PM 2C Building a Community Health
System Palliative Care Program:
2A One Size Doesn’t Fit All (The Butler
Hospice Quality Reporting Update
Health System Experience)
for Hospice Providers – Part II
Kathy J. Selvaggi, MS, MD, FAAHPM, Director-
Jennifer L. Kennedy, MA, BSN, CHC, Regulatory and Palliative Care and Dillon J. Stein, DO, Palliative
Compliance Director, National Hospice and Palliative Care Physician, Butler Health System
Care Organization Expansion of palliative care in communities where
Change happens! Is your organization on top of all the resources, understanding, and acceptance of palliative
recent regulatory changes affecting the hospice industry? care may vary remains a challenge. Programs fostered
This session will highlight the important regulatory issues by community health systems must be supported in ways
facing hospice providers today. Participants will receive tailored to the needs of smaller organizations and their
cutting edge information about what is happening within communities. We outline our approach taken to develop
CMS, the OIG, and other federal entities that affect a community health system palliative care program and
hospice care. discuss steps taken to impact patient care in our hospital,
health system, outpatient clinical and community during our
Learning Objectives: Review the current quality first three years.
reporting requirements and issues in the hospice industry.
Discuss quality reporting and QAPI requirements as Learning Objectives: Identify challenges in developing
separate yet integrated parts of a hospice quality program. quality palliative care in the community setting. Describe
2B Medication Interactions: community health system. Describe future directions
a method of programmatic growth of palliative care and
When One Plus One Equals Three!
for sustainable growth and expansion of a community
Mary Lynn McPherson, PharmD, MA, BCPS, CPE, palliative care program beyond hospital confines.
Professor and Vice Chair, Department of Pharmacy 2D Spirituality, the Unseen Essential
Practice and Science, University of Maryland School in Patient Care
of Pharmacy
Laura L. Barry, BS, MBA, M.Msc, Chaplain and
The Hatfields and the McCoys take on drug interactions Dawn Seiders, BS, MS, MD, Medical Director,
– pharmacokinetic, pharmacodynamic, synergistic, VNA Hospice of Philadelphia
additive and oppositional! Using a case-based approach,
participants will learn what a drug interaction IS, how Spirituality is an essential element of person-centered care
clinically significant it is, and risk mitigation strategies. and it has now emerged as a significant field in clinical
Participants will leave with a whole new appreciation practice, research, healthcare policy, and training. This
for how drug interactions are happening every single presentation highlights the importance of spirituality in
day in their patients, and the symptoms may often be clinical care, introduces the basic concepts in spirituality
misconstrued as part of the dying process! Just say NO to and medicine, and describes the evidence for spirituality
drug interactions! in health care. It also reviews the role of healthcare
professionals and spiritual care professionals in providing
Learning Objectives: Define “drug interaction” spiritual care to patients and family caregivers.
and differentiate between a pharmacokinetic and
pharmacodynamic drug. Describe risk assessment, Learning Objectives: Create understanding of and
diagnosis and management of six common clinical desire to incorporate spirituality in assessing patients.
syndromes caused by pharmacodynamic drug interactions. Apply the understanding of spiritual and cultural beliefs
Describe three example of a pharmacokinetic drug and behaviors to appropriate clinical contexts. Understand
interaction. and feel comfortable using spiritual assessment tools.

8